Trials / Recruiting
RecruitingNCT04937998
PRP Versus HA IN OSTEOARTHRITIS OF THE PATELLOFEMORAL JOINT
THE USE OF FRESH PRP VS HA IN THE TREATMENT OF OSTEOARTHRITIS OF THE PATELLOFEMORAL JOINT Randomized Controlled Clinical Trial
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 166 (estimated)
- Sponsor
- Istituto Ortopedico Rizzoli · Academic / Other
- Sex
- All
- Age
- 30 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to compare the 12-month clinical outcomes of patients with patellofemoral osteoarthritis undergoing infiltrative treatment with fresh PRP and HA
Detailed description
166 patients affected by patellofemoral osteoarthritis will be included in a double-blinded RCT. In this study one group of patients will be treated with 1 intra-articular injection of PRP (treatment arm) and one group will be treated with 1 intra-articular injection of HA (control arm). Patients will be followed-up with clinical evaluation at baseline and at 2.6.12 and 24 months. Questionnaires will be administered for clinical evaluations during the follow-up visits.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Autologous PRP injection | Patients will be treated with a single injection of Autologous PRP (5 ml) in the knee joint affected by patellofemoral osteoarthritis |
| PROCEDURE | HA injection | Patients will be treated with a single injections of Hyaluronic Acid (5 ml) in the knee joint affected by patellofemoral osteoarthritis |
Timeline
- Start date
- 2022-10-26
- Primary completion
- 2026-09-01
- Completion
- 2026-09-01
- First posted
- 2021-06-24
- Last updated
- 2025-12-04
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT04937998. Inclusion in this directory is not an endorsement.